vx has been researched along with 4-nitrophenol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhavaraju, MH; Chambers, HW; Chambers, JE; Funck, KE; Gwaltney, SR; Meek, EC; Pringle, RB | 1 |
| Briançon, S; Fessi, H; Hartmann, DJ; Ouvry, L; Pollet, T; Renaud, FN; Sellik, A | 1 |
2 other study(ies) available for vx and 4-nitrophenol
| Article | Year |
|---|---|
Novel nucleophiles enhance the human serum paraoxonase 1 (PON1)-mediated detoxication of organophosphates.
Topics: Antidotes; Aryldialkylphosphatase; Catalytic Domain; Enzyme Activation; Enzyme Activators; Humans; Hydrolysis; Hydroxides; Inactivation, Metabolic; Molecular Dynamics Simulation; Nitrophenols; Organothiophosphorus Compounds; Oximes; Pyridinium Compounds; Sarin; Spectrophotometry; Water | 2015 |
Degradation of paraoxon (VX chemical agent simulant) and bacteria by magnesium oxide depends on the crystalline structure of magnesium oxide.
Topics: Bacillus subtilis; Escherichia coli; Gas Chromatography-Mass Spectrometry; Magnesium Oxide; Metal Nanoparticles; Nitrophenols; Organothiophosphorus Compounds; Paraoxon; Particle Size; Spores, Bacterial; Staphylococcus aureus | 2017 |